Cited by 497Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults

Open access
Neeland, Ian J., Ayers, Colby R., Rohatgi, Anand K., Turer, Aslan T., Berry, Jarett D., Das, Sandeep R., Vega, Gloria L., Khera, Amit +3 more·2013·Obesity

Abstract

Objective : Visceral (VAT) and abdominal subcutaneous (SAT) adipose tissues contribute to obesity but may have different metabolic and atherosclerosis risk profiles. We sought to determine the associations of abdominal VAT and SAT mass with markers of cardiac and metabolic risk in a large, multiethnic, population‐based cohort of obese adults. Design and Methods : Among obese participants in the Dallas Heart Study, we examined the cross‐sectional associations of abdominal VAT and SAT mass, assessed by magnetic resonance imaging (MRI) and indexed to body surface area (BSA), with circulating biomarkers of insulin resistance, dyslipidemia, and inflammation ( n = 942); and with aortic plaque and liver fat by MRI and coronary calcium by computed tomography ( n = 1200). Associations of VAT/BSA and SAT/BSA were examined after adjustment for age, sex, race, menopause, and body mass index. Results : In multivariable models, VAT significantly associated with the homeostasis model assessment of insulin resistance (HOMA‐IR), lower adiponectin, smaller LDL and HDL particle size, larger VLDL size, and increased LDL and VLDL particle number ( p < 0.001 for each). VAT also associated with prevalent diabetes, metabolic syndrome, hepatic steatosis, and aortic plaque ( p < 0.001 for each). VAT independently associated with C‐reactive protein but not with any other inflammatory biomarkers tested. In contrast, SAT associated with leptin and inflammatory biomarkers, but not with dyslipidemia or atherosclerosis. Associations between SAT and HOMA‐IR were significant in univariable analyses but attenuated after multivariable adjustment. Conclusion : VAT associated with an adverse metabolic, dyslipidemic, and atherogenic obesity phenotype. In contrast, SAT demonstrated a more benign phenotype, characterized by modest associations with inflammatory biomarkers and leptin, but no independent association with dyslipidemia, insulin resistance, or atherosclerosis in obese individuals. These findings suggest that abdominal fat distribution defines distinct obesity sub‐phenotypes with heterogeneous metabolic and atherosclerosis risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.20135

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Visceral adipose tissue (VAT) appears to be associated with dyslipidemia and atherosclerosis, regardless of sex or race.

    “Visceral adipose tissue (VAT) appears to be associated with dyslipidemia and atherosclerosis, regardless of sex or race (19).”

    From The CardioMetabolic Health Alliance (2015) · cites this paper as [19]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Neeland, I. J., Ayers, C. R., Rohatgi, A. K., Turer, A. T., Berry, J. D., Das, S. R., Vega, G. L., Khera, A., McGuire, D. K., Grundy, S. M., & de Lemos, J. A.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Department of Internal Medicine Division of Cardiology University of Texas Southwestern Medical Center Dallas Texas USA
Venue
Obesity
Publisher
Wiley
Published
2013-05-19
Volume
21
Issue
9
Pages
E439-47
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W1848295836
Cited by
497
References
43
Citations by year
2026: 38 · 2025: 51 · 2024: 32 · 2023: 50 · 2022: 41 · 2021: 41 · 2020: 36 · 2019: 43 · 2018: 34 · 2017: 33 · 2016: 30 · 2015: 37 · 2014: 27 · 2013: 4
FWCI
22.23
Type
journal article
Language
en
Open access
Locations
  • Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR001105, UL1TR000451)
  • National Heart, Lung, and Blood Institute (T32HL007360)
  • National Institute of Diabetes and Digestive and Kidney Diseases (PL1DK081182)
  • National Institute of Dental and Craniofacial Research (UL1DE019584)
  • National Center for Research Resources (M01RR000633)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
visceral adipose tissue, subcutaneous abdominal fat, insulin resistance, dyslipidemia, atherosclerosis, aortic plaque, hepatic steatosis, coronary artery calcium, adiponectin, leptin, C-reactive protein, inflammation, metabolic syndrome, obesity-related diabetes, body fat distribution
MeSH terms
Adult, C-Reactive Protein, Female, Heart Diseases, Humans, Inflammation, Insulin Resistance, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Obesity, Phenotype, Cholesterol, VLDL, Biomarkers, Multivariate Analysis, Inflammation Mediators, Leptin, Metabolic Syndrome, Subcutaneous Fat, Intra-Abdominal Fat, Dyslipidemias, Atherosclerosis, Body Fat Distribution, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review